![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Prostate Cancer |
Free Subscription
1 Acta Radiol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Making an art into a science: a mathematical "Likert tool" can change PI-RADS
(v2) scores into Likert scores when reporting multiparametric MRI for prostate
cancer.
Acta Radiol. 2022 Jul 11:2841851221112194. doi: 10.1177/02841851221112194.
PubMed
Abstract available
Multi-institutional analysis of clinical and imaging risk factors for detecting
clinically significant prostate cancer in men with PI-RADS 3 lesions.
Cancer. 2022 Jul 12. doi: 10.1002/cncr.34355.
PubMed
Abstract available
Phase 1b Study of the BET Inhibitor GS-5829 as Monotherapy and Combined with
Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res. 2022 Jul 11. pii: 706956. doi: 10.1158/1078-0432.CCR-22-0175.
PubMed
Abstract available
Downregulation of PGM5 expression correlates with tumor progression and poor
prognosis in human prostate cancer.
Discov Oncol. 2022;13:63.
PubMed
Abstract available
Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic
Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission
Tomography.
Eur Urol. 2022;82:156-160.
PubMed
Abstract available
De Novo Neuroendocrine Features in Prostate Cancer.
Hum Pathol. 2022 Jul 7. pii: S0046-8177(22)00175.
PubMed
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline.
J Urol. 2022 Jul 5:101097JU0000000000002854. doi: 10.1097/JU.0000000000002854.
PubMed
The Added Value of Baseline Health-Related Quality of Life in Predicting Survival
in High-Risk Prostate Cancer Patients Following Radical Prostatectomy.
J Urol. 2022 Jul 5:101097JU0000000000002826. doi: 10.1097/JU.0000000000002826.
PubMed
Abstract available
DNMT1-mediated epigenetic silencing of TRAF6 promotes prostate cancer
tumorigenesis and metastasis by enhancing EZH2 stability.
Oncogene. 2022 Jul 8. pii: 10.1038/s41388-022-02404.
PubMed
Abstract available
Radiomics in prostate cancer: an up-to-date review.
Ther Adv Urol. 2022;14:17562872221109020.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by